<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03144115</url>
  </required_header>
  <id_info>
    <org_study_id>UESTC-neuSCAN-22</org_study_id>
    <nct_id>NCT03144115</nct_id>
  </id_info>
  <brief_title>Does Oxytocin Modulate Rewarding Effects in Women and Fluctuating Across the Menstrual Cycle</brief_title>
  <official_title>Does Oxytocin Modulate Rewarding Effect of Metaphorical Compliments Fluctuating With Women's Fertility and Luteal Phase in a Romantic Context</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Electronic Science and Technology of China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Electronic Science and Technology of China</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to explore how the rewarding effect of men's verbal compliment is
      modulated by oxytocin and gonadal hormone in a romantic context.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To investigate whether oxytocin (24IU) might interact with female sex hormone in modulating
      the rewarding effect of compliment to women in a romantic context.

      The study employs a double-blind, within-subject, placebo-control design. Women will be
      administered with the same drug twice (oxytocin or placebo) respectively the fertile and
      luteal phase followed by a MRI scanning. During fMRI participants will rate men's attraction
      based on their facial pictures of average attractiveness associated with compliments of
      different combination of form and topic. Each male face will be paired with two sentences of
      the same kind. After the fMRI participants will recall the judgment followed by a memory test
      during which they have to indicate whether the they have seen the face during scanning (old)
      or whether it is an unknown face (new).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oxytocin effect on neural activity as assessed via fMRI towards reward between fertility and luteal phases</measure>
    <time_frame>45min-120min after treatment</time_frame>
    <description>Effects of oxytocin versus placebo nasal spray on neural processing of reward will be compared between different cycle phases</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>oxytocin fertility</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intranasal oxytocin administration (24IU) in women's fertility phase (LH&gt;40 mIU/ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebos fertility</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intranasal placebo administration (24IU) in women's fertility phase (LH&gt;40 mIU/ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>oxytocin luteal</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>intranasal oxytocin administration (24IU) in women's luteal phase (LH&lt;30 mIU/ml)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebos luteal</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>intranasal placebos administration (24IU) in women's luteal phase (LH&lt;30 mIU/ml)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <arm_group_label>oxytocin fertility</arm_group_label>
    <arm_group_label>oxytocin luteal</arm_group_label>
    <other_name>oxytocin treatment</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebos</intervention_name>
    <arm_group_label>placebos fertility</arm_group_label>
    <arm_group_label>placebos luteal</arm_group_label>
    <other_name>placebo control</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Single in the past 3 months

          -  Healthy subjects with regular menstrual cycle

        Exclusion Criteria:

          -  Pregnant, menstruating, taking oral contraceptives

          -  metal implanted, with tatoo, or hair dyed within 6 months

          -  participated in another intranasal experiment within 6 months

          -  with a history of past or current psychiatric or neurological disorder
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>25 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Keith M Kendrick, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Electronic Science and Technology of China</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Keith M Kendrick, Dr.</last_name>
    <email>k.kendrick.uestc@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Benjamin Becker, Dr.</last_name>
    <email>ben_becker@gmx.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Electronic Science and Technology of Chia</name>
      <address>
        <city>Chengdu</city>
        <state>Sichuan</state>
        <zip>611731</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Keith M Kendrick, Dr.</last_name>
      <email>k.kendrick.uestc@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Benjamin Becker, Dr.</last_name>
      <email>ben_becker@gmx.de</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 4, 2017</study_first_submitted>
  <study_first_submitted_qc>May 4, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 8, 2017</study_first_posted>
  <last_update_submitted>February 6, 2018</last_update_submitted>
  <last_update_submitted_qc>February 6, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Electronic Science and Technology of China</investigator_affiliation>
    <investigator_full_name>Keith Kendrick</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>oxytocin</keyword>
  <keyword>sex hormone</keyword>
  <keyword>verbal reward</keyword>
  <keyword>mate selection</keyword>
  <keyword>metaphorical language</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

